Drug Trial Radar · NCT00887380
STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing)
Last checked: Nov 19, 2026Latest source record: Nov 18, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
2,023
Actual
Start
Sep 16, 2009
Primary completion
Dec 2024
Study completion Dec 2024
Sponsor
- Lead sponsor
- Trans Tasman Radiation Oncology GroupAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 24, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether starting anastrozole prior to radiotherapy, so that it is taken during radiotherapy, decreases local recurrence of breast cancer in post-menopausal women in comparison to waiting until after radiotherapy to commence anastrozole.
Conditions
- Breast Cancer
Interventions
Pre-radiotherapy commencement of anastrozoleDrug
Anastrozole: 1mg per day will be prescribed for 12 weeks. Commencing within 1 week of randomisation, to be administered from a min of 1 week before and a max of 4 weeks before commencement of radiotherapy and continued throughout radiotherapy. After 12 weeks administration of anastrozole according to trial regimen, anastrozole can be continued at the treating clinician's discretion and in accordance with the preference selected at the time of randomisation and stratification. The alternative options to long-term anastrozole are tamoxifen or cessation of anti-oestrogen therapy.
RadiotherapyRadiation
Radiotherapy must commence within 1 month of randomisation. Radiotherapy planning and treatment is as per the protocol.
Post radiotherapy commencement of anastrozoleDrug
Anastrozole 1mg per day will be prescribed for 12 weeks after radiotherapy is completed. Anastrozole should commence within 1 week of the last fraction of radiotherapy and be continued for a total of 12 weeks. After 12 weeks administration according to the trial regimen, any subsequent hormone therapy is as for the concurrent arm.
Primary outcomes
What the sponsor says the trial is designed to measure.
- To determine if commencement of anastrozole prior to radiotherapy results in improved local control compared to anastrozole commenced after radiotherapy.Time frame: 10 years post radiotherapy
Locations
34 sites in 2 countries. Site status is shown where the registry gives one.
The Canberra Hospital
Canberra, Australian Capital Territory, Australia
Campbelltown Hospital
Campbelltown, New South Wales, Australia
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
Genesis Cancer Care Hurstville
Hurstville, New South Wales, Australia
St George Hospital
Kogarah, New South Wales, Australia
Liverpool Hospital
Liverpool, New South Wales, Australia
Calvary Mater Newcastle
Newcastle, New South Wales, Australia
Central West Cancer Service
Orange, New South Wales, Australia
Prince of Wales Hospital
Randwick, New South Wales, Australia
Royal North Shore Hospital
St Leonards, New South Wales, Australia
Riverina Cancer Centre
Wagga Wagga, New South Wales, Australia
Illawarra Cancer Care Centre
Wollongong, New South Wales, Australia
Alan Walker Cancer Centre
Darwin, Northern Territory, Australia
Genesis Cancer Care
Auchenflower, Queensland, Australia
Cairns ROQ
Cairns, Queensland, Australia
Genesis Cancer Care
Chermside, Queensland, Australia
The Townsville Hospital
Douglas, Queensland, Australia
Radiation Oncology Gold Coast
Gold Coast, Queensland, Australia
Royal Brisbane and Women's Hospital
Herston, Queensland, Australia
Radiation Oncology - Mater Centre
South Brisbane, Queensland, Australia
Genesis Southport
Southport, Queensland, Australia
St Andrew's Toowoomba Hospital
Toowoomba, Queensland, Australia
Genesis Care
Tugun, Queensland, Australia
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Royal Hobart Hospital
Hobart, Tasmania, Australia
Geelong Hospital
Geelong, Victoria, Australia
Genesis Cancer Care
Bunbury, Western Australia, Australia
Fiona Stanley Hospital
Murdoch, Western Australia, Australia
Royal Perth Hospital
Perth, Western Australia, Australia
Perth Radiation Oncology
Wembley, Western Australia, Australia
Auckland Hospital
Auckland, New Zealand
Christchurch Hopsital Oncology Sevice
Christchurch, New Zealand
Palmerston North
Palmerston North, New Zealand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.